Lumos Pharma Inc.

NASDAQ: LUMO · Real-Time Price · USD
4.34
0.00 (0.00%)
At close: Dec 11, 2024, 10:00 PM

Lumos Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
35.08M 56.01M 94.81M
Short-Term Investments
999K 11.35M n/a
Long-Term Investments
n/a n/a n/a
Other Long-Term Assets
n/a -283K -635K
Receivables
210K 223K 128K
Inventory
n/a n/a n/a
Other Current Assets
3.75M 4.43M n/a
Total Current Assets
40.03M 72.01M 99.68M
Property-Plant & Equipment
603K 283K 635K
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
603K 283K 635K
Total Assets
40.64M 72.29M 100.31M
Account Payables
890K 275K 612K
Deferred Revenue
n/a n/a n/a
Short-Term Debt
282K 233K 352K
Other Current Liabilities
3.19M 3.5M 2.46M
Total Current Liabilities
7.03M 6.71M 5.13M
Long-Term Debt
n/a n/a n/a
Other Long-Term Liabilities
6M n/a 6M
Total Long-Term Liabilities
6.3M 6M 6.21M
Total Liabilities
13.33M 12.71M 11.34M
Total Debt
585K 233K 557K
Common Stock
81K 82K 83K
Retained Earnings
-161.52M -127.48M -96.42M
Comprehensive Income
-0.00 -9K 0.00
Shareholders Equity
27.3M 59.58M 88.98M
Total Investments
999K 11.35M n/a